Rhode Island considers ending Medicaid coverage of GLP-1 drugs for weight loss

Wegovy, which is used for weight loss, requires refrigeration because it’s not shelf-stable. (Photo by Alexander Castro/Rhode Island Current)

Rhode Island’s Medicaid program is contemplating an end to coverage for GLP-1 drugs prescribed for weight loss.

The proposal appears in the Rhode Island’s Executive Office of Health and Human Services’ 270-page operating budget submission for fiscal year 2027. The coverage change could take effect as early as July 1, 2026, but would more likely happen by October 2026 or January 2027, according to the budget request document — one of the many documents state agencies send to the governor’s office each fall with details on their monetary needs and challenges predicted in the upcoming fiscal year…

Story continues

TRENDING NOW

LATEST LOCAL NEWS